Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $113.5900 (-0.13%) ($110.5300 - $114.5000) on Thu. Jun. 6, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.1% (three month average) | RSI | 44 | Latest Price | $113.5900(-0.13%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.7% a day on average for past five trading days. | Weekly Trend | LGND declines -1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(57%) XBI(55%) IWC(54%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -1.05% in a week (0% probabilities). VXX(-21%) TLT(-15%) IFRA(-8%) UUP(-4%) IGOV(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.05% (StdDev 2.1%) | Hourly BBV | 0 () | Intraday Trend | -0.2% | | | |
|
5 Day Moving Average | $111.94(1.47%) | 10 Day Moving Average | $111.92(1.49%) | 20 Day Moving Average | $113.29(0.26%) | To recent high | -12.2% | To recent low | 7.2% | Market Cap | $1.826b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |